Chronic Kidney Disease Collaboration, Global Burden of Disease. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709–733 (2020).
Chadban, S. J. et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J. Am. Soc. Nephrol. 14, S131–S138 (2003).
Coresh, J. et al. Prevalence of chronic kidney disease in the United States. JAMA 298, 2038–2047 (2007).
Article CAS PubMed Google Scholar
Fletcher, J., McDonald, S., Alexander, S. I. & Australian & New Zealand Pediatric Nephrology Association. Prevalence of genetic renal disease in children. Pediatr. Nephrol. 28, 251–256 (2013).
Hildebrandt, F. Decade in review-genetics of kidney diseases: genetic dissection of kidney disorders. Nat. Rev. Nephrol. 11, 635–636 (2015).
Article CAS PubMed PubMed Central Google Scholar
Vivante, A. & Hildebrandt, F. Exploring the genetic basis of early-onset chronic kidney disease. Nat. Rev. Nephrol. 12, 133–146 (2016).
Article CAS PubMed PubMed Central Google Scholar
Cocchi, E., Nestor, J. G. & Gharavi, A. G. Clinical genetic screening in adult patients with kidney disease. Clin. J. Am. Soc. Nephrol. 15, 1497–1510 (2020).
Article CAS PubMed PubMed Central Google Scholar
Mallett, A. et al. The prevalence and epidemiology of genetic renal disease amongst adults with chronic kidney disease in Australia. Orphanet J. Rare Dis. 9, 98 (2014).
Article PubMed PubMed Central Google Scholar
Schrezenmeier, E. et al. The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation. Genet. Med. 23, 1219–1224 (2021).
Article CAS PubMed PubMed Central Google Scholar
Snoek, R. et al. Genetics-first approach improves diagnostics of ESKD patients <50 years old. Nephrol. Dial. Transpl. 37, 349–357 (2022).
Sedor, J. R. APOL1 kidney disease: discovery to targeted therapy in 10 years. Clin. J. Am. Soc. Nephrol. 19, 126–128 (2023).
Cornec-Le Gall, E., Alam, A. & Perrone, R. D. Autosomal dominant polycystic kidney disease. Lancet 393, 919–935 (2019).
Mallett, A. J., Knoers, N., Sayer, J. & Stark, Z. Clinical versus research genomics in kidney disease. Nat. Rev. Nephrol. 17, 570–571 (2021).
Groopman, E. E. et al. Diagnostic utility of exome sequencing for kidney disease. N. Engl. J. Med. 380, 142–151 (2019).
Article CAS PubMed Google Scholar
Jayasinghe, K. et al. Clinical impact of genomic testing in patients with suspected monogenic kidney disease. Genet. Med. 23, 183–191 (2021).
Tanudisastro, H. A. et al. Australia and New Zealand renal gene panel testing in routine clinical practice of 542 families. NPJ Genom. Med. 6, 20 (2021).
Article PubMed PubMed Central Google Scholar
Dahl, N. K. et al. The clinical utility of genetic testing in the diagnosis and management of adults with chronic kidney disease. J. Am. Soc. Nephrol. 34, 2039–2050 (2023).
Claus, L. R., Snoek, R., Knoers, N. & van Eerde, A. M. Review of genetic testing in kidney disease patients: Diagnostic yield of single nucleotide variants and copy number variations evaluated across and within kidney phenotype groups. Am. J. Med. Genet. C. Semin. Med. Genet. 190, 358–376 (2022).
Article CAS PubMed PubMed Central Google Scholar
Jayasinghe, K. et al. Cost-effectiveness of targeted exome analysis as a diagnostic test in glomerular diseases. Kidney Int. Rep. 6, 2850–2861 (2021).
Article PubMed PubMed Central Google Scholar
Wu, Y. et al. Genomic testing for suspected monogenic kidney disease in children and adults: a health economic evaluation. Genet. Med. 25, 100942 (2023).
Article CAS PubMed Google Scholar
Becherucci, F. et al. A clinical workflow for cost-saving high-rate diagnosis of genetic kidney diseases. J. Am. Soc. Nephrol. 34, 706–720 (2023).
Article PubMed PubMed Central Google Scholar
Garrelfs, S. F. et al. Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1. N. Engl. J. Med. 384, 1216–1226 (2021).
Article CAS PubMed Google Scholar
Germain, D. P. et al. An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease. Mol. Genet. Metab. 137, 49–61 (2022).
Article CAS PubMed Google Scholar
Heather, J. M. & Chain, B. The sequence of sequencers: the history of sequencing DNA. Genomics 107, 1–8 (2016).
Article CAS PubMed Google Scholar
Shendure, J. et al. DNA sequencing at 40: past, present and future. Nature 550, 345–353 (2017).
Article CAS PubMed Google Scholar
Lander, E. S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860–921 (2001).
Article CAS PubMed Google Scholar
Venter, J. C. et al. The sequence of the human genome. Science 291, 1304–1351 (2001).
Article CAS PubMed Google Scholar
Stark, Z. et al. Integrating genomics into healthcare: a global responsibility. Am. J. Hum. Genet. 104, 13–20 (2019).
Article CAS PubMed PubMed Central Google Scholar
Gilissen, C., Hoischen, A., Brunner, H. G. & Veltman, J. A. Unlocking Mendelian disease using exome sequencing. Genome Biol. 12, 228 (2011).
Article CAS PubMed PubMed Central Google Scholar
Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424 (2015).
Article PubMed PubMed Central Google Scholar
Rehm, H. L. et al. GA4GH: International policies and standards for data sharing across genomic research and healthcare. Cell Genom 1, 100029 (2021).
Austin-Tse, C. A. et al. Best practices for the interpretation and reporting of clinical whole genome sequencing. NPJ Genom. Med. 7, 27 (2022).
Article PubMed PubMed Central Google Scholar
Stark, Z. et al. Scaling national and international improvement in virtual gene panel curation via a collaborative approach to discordance resolution. Am. J. Hum. Genet. 108, 1551–1557 (2021).
Article CAS PubMed PubMed Central Google Scholar
Yuskaitis, C. J., Sheidley, B. R. & Poduri, A. Variability among next-generation sequencing panels for early-life epilepsies. JAMA Pediatr. 172, 779–780 (2018).
留言 (0)